Brief: Ideaya Biosciences Announces Ind-Clearance For Werner Helicase Development Candidate Ide275 (Gsk959) For A Phase 1 Study In Msi-High Solid Tumors
28/10/2024 10:18
Oct 28 (Reuters) - IDEAYA Biosciences Inc IDYA.O :
* IDEAYA BIOSCIENCES ANNOUNCES IND-CLEARANCE FOR WERNER
HELICASE
DEVELOPMENT CANDIDATE IDE275 (GSK959) FOR A PHASE 1 STUDY IN
MSI-HIGH SOLID TUMORS
Source text: ID:nPnxdNL5a
Further company coverage: IDYA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on IDEAYA Biosciences
See all newsBrief: Ideaya Biosciences And Servier Announce Data From Three Clinical Trials At Esmo 2026 Supporting The Potential Of Darovasertib To Become A Foundational New Therapy For Patients Across The Treatment Journey Of Uveal Melanoma
Brief: Ideaya Biosciences Announces The Promotion Of Dr. Michael White To President, Research And Development
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj